Eledon Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Eledon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $77M.
  • Eledon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$21.7M, a 85% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$117M, a 32.5% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$88M, a 155% decline from 2021.
  • Eledon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$34.5M, a 51.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$117M -$28.6M -32.5% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-08-19
2022 -$88M -$53.5M -155% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-08-19
2021 -$34.5M -$11.7M -51.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$22.8M -$6.8M -42.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$16M -$1.95M -13.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$14.1M -$949K -7.24% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-17
2017 -$13.1M -$7.46M -132% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 -$5.66M +$39.4M +87.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$45.1M -$21.8M -93.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-03
2014 -$23.3M -$7.57M -48.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 -$15.7M -$6.08M -63% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 -$9.65M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.